KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Receivables (2016 - 2026)

Clorox has reported Receivables over the past 18 years, most recently at $671.0 million for Q1 2026.

  • For Q1 2026, Receivables rose 12.4% year-over-year to $671.0 million; the TTM value through Mar 2026 reached $671.0 million, up 12.4%, while the annual FY2025 figure was $837.0 million, 14.03% up from the prior year.
  • Receivables for Q1 2026 was $671.0 million at Clorox, roughly flat from $671.0 million in the prior quarter.
  • Over five years, Receivables peaked at $837.0 million in Q2 2025 and troughed at $581.0 million in Q3 2023.
  • A 5-year average of $664.6 million and a median of $671.0 million in 2025 define the central range for Receivables.
  • On a YoY basis, Receivables climbed as much as 18.15% in 2025 and fell as far as 11.29% in 2025.
  • Year by year, Receivables stood at $600.0 million in 2022, then increased by 13.17% to $679.0 million in 2023, then dropped by 11.19% to $603.0 million in 2024, then grew by 11.28% to $671.0 million in 2025, then changed by 0.0% to $671.0 million in 2026.
  • Business Quant data shows Receivables for CLX at $671.0 million in Q1 2026, $671.0 million in Q4 2025, and $703.0 million in Q3 2025.